Prakash M, Myers J, Froelicher V F, Marcus R, Do D, Kalisetti D, Froning J, Atwood J E
Division of Cardiovascular Medicine, Stanford University Medical Center, Palo Alto, Calif., USA.
Am Heart J. 2001 Jul;142(1):127-35. doi: 10.1067/mhj.2001.115795.
Our purpose was to report the prevalence of abnormal treadmill test responses and their association with mortality in a large consecutive series of patients referred for standard diagnostic exercise tests, with testing performed and reported in a standardized fashion.
Exercise testing is widely performed, but an analysis of responses has not been presented for a large number of consecutive tests performed on patients referred for diagnosis of cardiac disease.
All patients referred for evaluation at 2 university-affiliated Veterans Affairs Medical Centers who underwent exercise treadmill tests for clinical indications between 1987 and 2000 were determined to be dead or alive according to the Social Security Death Index after a mean 5.9-year follow-up. Patients with established heart disease (ie, prior coronary bypass surgery, myocardial infarction, or congestive heart failure) were excluded from analyses. Clinical and exercise test variables were collected prospectively according to standard definitions; testing and data management were performed in a standardized fashion with a computer-assisted protocol. All-cause mortality was used as the end point for follow-up. Standard survival analysis was performed, including Kaplan-Meier curves and a Cox hazard model.
After the exclusions, 3974 men (mean age 57.5 +/- 11 years) had standard diagnostic exercise testing over the study period with a mean of 5.9 (+/-3.7) years of follow-up (64% of all tested). There were no complications of testing in this clinically referred population, 82% of whom were referred for chest pain, risk factors, or signs and symptoms of ischemic heart disease. Five hundred forty-nine (14%) had a history of typical angina. Indications for testing were in accordance with published guidelines. A total of 545 died, yielding an annual mortality rate of 1.8%. The Cox hazard model chose the following variables in rank order as independently associated with time to death: change in rate pressure product, age greater than 65 years, METs less than 5, and electrocardiographic left ventricular hypertrophy. A score based on these variables classified patients into low-, medium-, and high-risk groups. The high-risk group with a score greater than 3 has a hazard ratio of 4 (95% confidence interval 3.82-4.27) and an annual mortality rate of 4%.
This comprehensive analysis provides rates of various abnormal responses that can be expected in men referred for diagnostic exercise testing at typical Veterans Administration Medical Centers. Four simple variables combined as a score predict all-cause mortality after clinical decisions for therapy are prescribed.
我们的目的是报告在一大组连续接受标准诊断性运动试验的患者中,异常跑步机试验反应的发生率及其与死亡率的关联,试验以标准化方式进行并报告。
运动试验广泛开展,但尚未有针对大量连续转诊以诊断心脏病的患者的试验反应分析。
对1987年至2000年间在2家大学附属退伍军人事务医疗中心因临床指征接受运动跑步机试验的所有患者,根据社会保障死亡指数确定其在平均5.9年随访后的生死情况。已确诊心脏病(即既往冠状动脉搭桥手术、心肌梗死或充血性心力衰竭)的患者被排除在分析之外。根据标准定义前瞻性收集临床和运动试验变量;试验和数据管理采用标准化方式并借助计算机辅助方案进行。全因死亡率用作随访终点。进行标准生存分析,包括Kaplan-Meier曲线和Cox风险模型。
排除后,3974名男性(平均年龄57.5±11岁)在研究期间接受了标准诊断性运动试验,平均随访5.9(±3.7)年(占所有受试患者的64%)。在这个临床转诊人群中试验无并发症,其中82%因胸痛、危险因素或缺血性心脏病的体征和症状而转诊。549人(14%)有典型心绞痛病史。试验指征符合已发表的指南。共有545人死亡,年死亡率为1.8%。Cox风险模型按重要性顺序选择以下变量作为与死亡时间独立相关的因素:心率血压乘积变化、年龄大于65岁、代谢当量小于5以及心电图左心室肥厚。基于这些变量的评分将患者分为低、中、高风险组。评分大于3的高风险组风险比为4(95%置信区间3.82 - 4.27),年死亡率为4%。
这项综合分析提供了在典型退伍军人管理医疗中心接受诊断性运动试验的男性中可能出现的各种异常反应的发生率。四个简单变量组合成一个评分可在临床确定治疗方案后预测全因死亡率。